Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Nct04512345 roflumilast?Ibrance generic name?Ubrelvy cost without insurance?Clonidine 0 2 mg patch price?Spravato sales revenue 2025 2026 janssen?
See the DrugPatentWatch profile for trokendi
Trokendi is the brand name for topiramate, an anti-seizure medicine used to treat epilepsy and other conditions. It comes in forms that can be taken by mouth, including an extended-release version (often labeled Trokendi XR).
Trokendi (topiramate) is used for seizure disorders and may also be prescribed for migraine prevention, depending on the specific formulation and the patient’s diagnosis.
Topiramate affects brain signaling in ways that help reduce abnormal electrical activity. It is classified as an anticonvulsant and works through multiple mechanisms, which is why it can help with both seizures and migraine prevention in appropriate patients.
Patients often see both immediate-release and extended-release topiramate products. Trokendi XR specifically refers to the extended-release formulation, which is designed to release medication more slowly over time.
For background on topiramate brand products, including any patent or exclusivity notes, DrugPatentWatch.com is a useful reference: https://www.drugpatentwatch.com/
Other Questions About Trokendi :